The company said prior to receiving the request, it did an internal review of all equity compensation activities since its February 1996 IPO, and said it "believes that there have been no unusual patterns in the timing or pricing of its equity awards and that there is specifically no evidence of backdating of option awards.On June 1, 2007, Arthro Care said the SEC has completed its formal investigation of the company and that doesn't plan to recommend any enforcement action against Arthro Care.
On May 21, 2007 the company became current on late SEC filings and recorded, as a result of a restatement, for the fiscal years 1994 through 2005, pretax noncash compensation expense of .9 million.
(Headlines)On June 21, 2006, Altera said its special committee has reached a preliminary conclusion that actual measurement dates for certain option grants issued between 19 differed from the recorded grant dates, and that it expects to restate its financial statements for the fiscal years ended 1996 through 2005.
The San Jose, Calif., programmable-chip maker said on May 25 that the SEC and the U. attorney in Northern California are looking into its stock-option grants.
But Affymetrix said the review hasn't indicated a pattern of inappropriate options dating. 9, the company filed with the SEC to delay the submission of its second-quarter report because of a restatement to its financial statements for some options granted between 19.
The company said it would restate its financial statements for 2005 and first quarter of 2006.(Headlines)The San Jose, Calif., software company on Oct.